Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 3
1991 2
1992 1
1993 2
1994 5
1995 4
1996 3
1997 1
1998 5
1999 4
2000 5
2001 4
2002 7
2003 6
2004 7
2005 15
2006 4
2007 7
2008 2
2009 2
2010 1
2011 7
2012 3
2013 7
2014 8
2015 9
2016 14
2017 7
2018 10
2019 8
2020 6
2021 9
2022 3
2023 7
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.
Babiker A, Li X, Lai YL, Strich JR, Warner S, Sarzynski S, Dekker JP, Danner RL, Kadri SS. Babiker A, et al. Among authors: dekker jp. Lancet Infect Dis. 2021 May;21(5):697-710. doi: 10.1016/S1473-3099(20)30523-5. Epub 2020 Dec 14. Lancet Infect Dis. 2021. PMID: 33333013 Free PMC article. Review.
Salmonella, Shigella, and yersinia.
Dekker JP, Frank KM. Dekker JP, et al. Clin Lab Med. 2015 Jun;35(2):225-46. doi: 10.1016/j.cll.2015.02.002. Epub 2015 Apr 2. Clin Lab Med. 2015. PMID: 26004640 Free PMC article. Review.
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, Demirkale CY, Dekker JP, Palmore TN, Rhee C, Klompas M, Hooper DC, Powers JH 3rd, Srinivasan A, Danner RL, Adjemian J; forming the National Insititutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI). Kadri SS, et al. Among authors: dekker jp. Lancet Infect Dis. 2021 Feb;21(2):241-251. doi: 10.1016/S1473-3099(20)30477-1. Epub 2020 Sep 8. Lancet Infect Dis. 2021. PMID: 32916100 Free PMC article.
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, Palmore TN, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Suffredini AF, Hooper DC, Fridkin S, Danner RL; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI). Kadri SS, et al. Among authors: dekker jp. Clin Infect Dis. 2018 Nov 28;67(12):1803-1814. doi: 10.1093/cid/ciy378. Clin Infect Dis. 2018. PMID: 30052813 Free PMC article.
185 results